Search

Your search keyword '"Strazzabosco, M."' showing total 96 results

Search Constraints

Start Over You searched for: Author "Strazzabosco, M." Remove constraint Author: "Strazzabosco, M." Topic business.industry Remove constraint Topic: business.industry
96 results on '"Strazzabosco, M."'

Search Results

1. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

2. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

3. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey

4. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

5. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

6. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study

7. HUMAN LEUKOCYTE ANTIGEN POLYMORPHISMS IN ITALIAN PRIMARY BILIARY CIRRHOSIS: A MULTICENTER STUDY OF 664 PATIENTS AND 1992 HEALTHY CONTROLS

8. Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study

9. Hepatitis B-core Antibody Positive Donors in Liver Transplantation and Their Impact on Graft Survival: Evidence From The Liver Match Cohort Study

10. A prospective multicentre survey on the treatment of acute pancreatitis in Italy

11. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

12. Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options

13. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study

14. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching

15. Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants

16. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in MicrobiotaSummary

17. Health Related Quality of Life in Chronic Liver Diseases

18. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

19. Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine

20. Value‐based care in hepatology

21. Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma

22. Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

23. Fibrocystic Liver Disease

24. Animal models for cystic fibrosis liver disease (CFLD)

25. Animal models of cholestasis: An update on inflammatory cholangiopathies

26. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases

27. Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma

28. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances

29. Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions

30. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases

31. Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies

32. Animal models of cholangiocarcinoma: What they teach us about the human disease

33. Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat

34. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

35. The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities

36. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness

37. Difference in health related quality of life of chronic liver diseases and general population

38. Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience

39. Impact of multidisciplinary team approach to liver tumors: 5-Years experience

40. Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study

41. The challenges of primary biliary cholangitis: What is new and what needs to be done

42. Emerging concepts in biliary repair and fibrosis

43. Liver-allocation policies for patients affected by HCC in Europe

44. Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis

45. A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

46. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

47. GENDER DIFFERENCES IN HCV CHRONIC LIVER DISEASE: A REAL LIFE EVALUATION IN PITER (PIATTAFORMA ITALIANA PER LO STUDIO DELLA TERAPIA DELLE EPATITI VIRALI) COHORT STUDY

48. 'The city of Hepar': Rituals, gastronomy, and politics at the origins of the modern names for the liver

49. A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C

50. Treatment With Pegylated Interferon and Ribavirin for Hepatitis C Virus-associated Severe Cryoglobulinemia in a Liver/Kidney Transplant Recipient

Catalog

Books, media, physical & digital resources